Markus David Siegelin

机构：Columbia University Irving Medical Center, Columbia University · ORCID：0000-0001-7113-3634

发表论文 243 篇 · 总被引 7329 次 · h-index 50

代表论文

• Association of MGMT Promoter Methylation With Survival in Low-grade and Anaplastic Gliomas After Alkylating Chemotherapy (2023 · JAMA Oncology · 被引 56)
• A cell state-specific metabolic vulnerability to GPX4-dependent ferroptosis in glioblastoma (2024 · The EMBO Journal · 被引 35)
• Osteopontin drives neuroinflammation and cell loss in MAPT-N279K frontotemporal dementia patient neurons (2024 · Cell stem cell · 被引 32)
• MGMT Promoter Methylation Predicts Overall Survival after Chemotherapy for 1p/19q-Codeleted Gliomas (2023 · Clinical Cancer Research · 被引 28)
• Tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro (2024 · British Journal of Cancer · 被引 15)
• Targeting cellular respiration as a therapeutic strategy in glioblastoma (2023 · Oncotarget · 被引 15)